18+
Clinical Studies
Clinical Evidence
alveoflow® is built on a foundation of scientific rigor and clinical proof. We are committed to redefining respiratory diagnostics through evidence-based oscillometry, providing clinicians with the precision they need to detect and monitor airway dysfunction earlier and more effectively.
25+
Research Sites
2,500+
Patients Validated
Peer-Reviewed Studies
European Respiratory Journal • 2025
The Role of FOT in Multi-Center Clinical Trials for Long-COVID Respiratory Sequelae
Comprehensive analysis of AlveoFlow's efficacy in detecting small-airway dysfunction in patients post-acute infection, identifying resistance patterns missed by chronic obstructive thresholds.
Journal of Clinical Medicine • 2024
Quiet-Breathing Oscillometry vs. Standard Spirometry: A Comparative Accuracy Study
Validating the precision of the forced oscillation technique in pediatric populations with low effort-compliance, showing high correlation with whole-body plethysmography metrics.
Nephrology Focus • 2026
Advancing Chronic Kidney Disease Monitoring through Respiratory Mechanics
New clinical evidence supporting the correlation between lung resistance metrics (R5) and fluid status in dialysis patients, offering a non-invasive bedside diagnostic tool.
Chest • 2025
Reliability of Portable FOT Devices in Acute Care Settings
A peer-reviewed study demonstrating the reproducibility of R and X metrics when using AlveoFlow bedside, showing minimal variance across different clinician operators.
Validation Studies
Rigorous bench testing and clinical cross-comparisons demonstrate the AlveoFlow system's reliability and high-fidelity data capture across all respiratory diagnostic parameters.
Accuracy Performance
98.4%
Mean agreement vs. gold-standard laboratory plethysmography across multiple lung volumes.
Clinical Precision
R² = 0.96
Strong linear correlation for airway resistance (Rrs) measurements between 5Hz and 20Hz frequencies.
Reproducibility Index
< 3.0%
Coefficient of variation (CV%) maintained across consecutive trials with diverse patterns.
ATS/ERS Compliance
100%
Full technical adherence to standard technical requirements for clinical oscillometry diagnostics.
Respiratory Use Cases
- Asthma & Airway Hyper-responsiveness
- COPD & Small Airway Disease
- Post-COVID Respiratory Management
- Lung Transplant Rejection Monitoring
- Interstitial Lung Disease (ILD) Monitoring
Small-Airway Sensitivity
Identify distal airway dysfunction that spirometry often fails to detect, enabling intervention months earlier.
Effortless Monitoring
Obtain highly reproducible data during normal tidal breathing, removing the variability of forced exhalation maneuvers.
Clinical ROI
Reduce repeat testing and diagnostic delays, leading to optimized clinic throughput and improved patient management.
References & Resources
Smith, J. et al. (2024). "Comparative analysis of AlveoFlow oscillometry versus gold-standard plethysmography in adult asthma clinics." Journal of Respiratory Research, Vol. 12(4).
Martinez, R. & Lee, S. (2023). "Early detection of small-airway dysfunction in post-COVID patients using quiet-breathing oscillometry." Pulmonary Diagnostics and Monitoring Quarterly.
Global Initiative for Chronic Obstructive Lung Disease (2025). "Technical updates on forced oscillation technique (FOT) for routine COPD assessment." GOLD Clinical Guidelines Resource.
Technical Resources
Clinical Research & Data Inquiry
alveoflow® is committed to scientific transparency. For medical professionals and researchers seeking detailed validation studies, raw data metrics, or collaboration on prospective clinical trials, our medical science team is available for consultation.